Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.
Charlene Kabel, PharmD, BCOP
Advertisement
Charlene Kabel, PharmD, BCOP
Barnes-Jewish Hospital
Articles by Charlene Kabel, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bepirovirsen Shows Breakthrough Potential for Functional Cure in Chronic Hepatitis B
2
Lingering Muscle Damage After Weight Restoration in Anorexia Nervosa May Require Long-Term Care
3
Pharmacist-Led Dietary Guidance Supports Kidney Health
4
BTK Inhibitors with CAR T-cell Therapy
5